Growth Metrics

Inogen (INGN) EBIT (2016 - 2022)

Historic EBIT for Inogen (INGN) over the last 10 years, with Q3 2022 value amounting to -$10.3 million.

  • Inogen's EBIT fell 26146.85% to -$10.3 million in Q3 2022 from the same period last year, while for Sep 2022 it was -$13.5 million, marking a year-over-year decrease of 22764.93%. This contributed to the annual value of $9.2 million for FY2021, which is 17683.99% up from last year.
  • According to the latest figures from Q3 2022, Inogen's EBIT is -$10.3 million, which was down 26146.85% from -$2.9 million recorded in Q2 2022.
  • In the past 5 years, Inogen's EBIT ranged from a high of $14.0 million in Q2 2018 and a low of -$10.3 million during Q3 2022
  • In the last 5 years, Inogen's EBIT had a median value of $4.8 million in 2018 and averaged $2.6 million.
  • In the last 5 years, Inogen's EBIT skyrocketed by 59642.71% in 2021 and then plummeted by 26146.85% in 2022.
  • Over the past 5 years, Inogen's EBIT (Quarter) stood at $4.8 million in 2018, then tumbled by 211.43% to -$5.3 million in 2019, then fell by 3.78% to -$5.5 million in 2020, then fell by 20.84% to -$6.7 million in 2021, then plummeted by 54.23% to -$10.3 million in 2022.
  • Its EBIT stands at -$10.3 million for Q3 2022, versus -$2.9 million for Q2 2022 and -$6.7 million for Q4 2021.